Firstline pembrolizumab for metastatic urothelial cancer

Adjuvant immunotherapy improves melanoma outcomes

Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer

FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer

Fulvestrant in FALCON trial improves PFS in advanced breast cancer

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial

Ribociclib improves progression-free survival in advanced breast cancer

Outcome of ovarian cancer patients was significantly improved with niraparib

Niraparib significantly improves outcomes for ovarian cancer patients

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Ribociclib improves PFS for postmenopausal women with hormone receptor-positive breast cancer

Cancer care in Wales - challenges and opportunities